Samsung’s ADC segregated suite, equipped with a 500-liter reactor, supports the development and manufacture of ADC therapies.

Investors sell off AMD shares despite the company's pivot to life sciences AI, following a rating downgrade by HSBC that followed a six-month decline in the stock price.

View eBook In the rapidly developing field of spatial biology, researchers are working to expand our understanding of ...

Intravenous BCG vaccine with a built-in kill-switch was found to be at least as effective as regular tuberculosis vaccine in ...

A new predictive AI system has been developed to predict gene activity in human cells with high precision. Researchers at ...

High-resolution of cellular heterogeneity from the molecular to circuit level reveals the molecular logic driving cellular ...

A new technology, mvGPT, is capable of precisely editing genes, activating gene expression, and repressing genes all at the ...

A new study reveals new insights into ependymal cells and astrocytes and offers a promising approach for future SCI therapies ...

Researchers eventually want to map the effects of every possible mutation on all human proteins to transform precision ...

A Danish team thinks it can aid rAAV manufacturers, who may not be able to spend three to five years working on a project ...

The adenine base editor corrected the most common mutation associated with Stargardt disease in the ABCA4 gene with no off-target effects.

VIVEbiotech is also collaborating with a range of different suppliers to make its operations as efficient as possible.